| 02/04/24 | 07:03:05 | 2 Apr 2024 | | New intellectual property strategy initiated |
| 25/03/24 | 07:25:30 | 25 Mar 2024 | | Incanthera provides Comm'l Update/Revenue F'casts |
| 19/03/24 | 07:00:11 | 19 Mar 2024 | | Grant of Share Options |
| 14/03/24 | 07:00:11 | 14 Mar 2024 | | IMMUPHARMA AT BIO-EUROPE SPRING 2024 |
| 06/03/24 | 07:00:09 | 6 Mar 2024 | | Financial, Business and Portfolio Develop't Update |
| 28/12/23 | 13:35:44 | 28 Dec 2023 | | Holding(s) in Company |
| 19/12/23 | 14:50:48 | 19 Dec 2023 | | Holding(s) in Company |
| 19/12/23 | 07:00:12 | 19 Dec 2023 | | Simbec-Orion appointed as CRO |
| 18/12/23 | 07:15:00 | 18 Dec 2023 | | Incanthera - Comm'l Skincare Deal/£1M Fundraise |
| 13/09/23 | 15:47:06 | 13 Sept 2023 | | Holding(s) in Company |
| 07/09/23 | 07:00:07 | 7 Sept 2023 | | Result of Retail Offer and Director Shareholding |
| 06/09/23 | 13:53:00 | 6 Sept 2023 | | Holding(s) in Company |
| 31/08/23 | 07:02:01 | 31 Aug 2023 | | WRAP Retail Offer for up to £0.5m |
| 31/08/23 | 07:01:01 | 31 Aug 2023 | | Subscription to raise £1.35m; Sharing Agr, RPT |
| 31/08/23 | 07:00:06 | 31 Aug 2023 | | Interim results |
| 21/08/23 | 07:00:03 | 21 Aug 2023 | | Extension of warrants in Incanthera plc |
| 11/08/23 | 12:04:47 | 11 Aug 2023 | | Directorate Change |
| 30/06/23 | 13:12:37 | 30 Jun 2023 | | Result of AGM |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | | Lupuzor Update |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | | IMM RNS Posting of RA and Notice of AGM 30 June 23 |
| 18/05/23 | 07:00:07 | 18 May 2023 | | Positive Pre-IND meeting with FDA |
| 11/05/23 | 07:00:04 | 11 May 2023 | | Final Results |
| 10/05/23 | 13:56:36 | 10 May 2023 | | Holding(s) in Company |
| 19/04/23 | 07:00:05 | 19 Apr 2023 | | Lupozor Update - FDA confirms Type-C meeting date |
| 12/04/23 | 07:00:03 | 12 Apr 2023 | | CIDP P140 Clinical Program Update |
| 27/03/23 | 07:00:04 | 27 Mar 2023 | | Lupuzor™ Update |
| 09/03/23 | 16:35:29 | 9 Mar 2023 | | Price Monitoring Extension |
| 06/03/23 | 07:00:03 | 6 Mar 2023 | | Collaboration with Orano on ImmuPharma Peptide |
| 06/02/23 | 07:00:03 | 6 Feb 2023 | | Lupuzor™ Update |
| 27/01/23 | 16:25:02 | 27 Jan 2023 | | TR-1: Notification of major holdings |
| 04/01/23 | 17:26:38 | 4 Jan 2023 | | TR-1: Notification of major holdings |
| 04/01/23 | 16:40:26 | 4 Jan 2023 | | Second Price Monitoring Extn |
| 04/01/23 | 16:35:05 | 4 Jan 2023 | | Price Monitoring Extension |
| 03/01/23 | 16:58:49 | 3 Jan 2023 | | TR-1: Notification of major holdings |
| 22/12/22 | 07:55:00 | 22 Dec 2022 | | Grant of Options |
| 22/12/22 | 07:00:05 | 22 Dec 2022 | | End of Year Update |
| 22/11/22 | 15:15:25 | 22 Nov 2022 | | Holding(s) in Company |
| 14/11/22 | 16:40:29 | 14 Nov 2022 | | Second Price Monitoring Extn |
| 14/11/22 | 16:35:23 | 14 Nov 2022 | | Price Monitoring Extension |
| 11/11/22 | 07:31:50 | 11 Nov 2022 | | Lupuzor Update |
| 11/10/22 | 16:40:27 | 11 Oct 2022 | | Second Price Monitoring Extn |
| 11/10/22 | 16:35:18 | 11 Oct 2022 | | Price Monitoring Extension |
| 07/10/22 | 16:44:39 | 7 Oct 2022 | | Company Secretary Change |
| 06/10/22 | 17:17:58 | 6 Oct 2022 | | Holding(s) in Company |
| 30/09/22 | 07:30:05 | 30 Sept 2022 | | Lupuzor Update |
| 30/09/22 | 07:00:14 | 30 Sept 2022 | | Interim Results or the 6mths Ended 30 June 2022 |
| 29/09/22 | 16:40:41 | 29 Sept 2022 | | Second Price Monitoring Extn |
| 29/09/22 | 16:37:13 | 29 Sept 2022 | | Price Monitoring Extension |
| 14/09/22 | 10:04:11 | 14 Sept 2022 | | Written Response received from the FDA |
| 07/09/22 | 08:25:36 | 7 Sept 2022 | | Exercise of Options |
